Innovating Works

ONCOTYROL

Desconocido
PERMIDES: Personsalised Medicine Innovation through Digital Enterprise Solutions ONCOTYROLCENTER FOR PERSONALIZED CANCER MEDICINE GMBH participó en un H2020: H2020-INNOSUP-2014-2015 It is the aim of PERMIDES to strenghten the competitiveness and foster the innovation potential of Personalized Medicine as an Emerging Indu...
2016-06-16 - 2018-08-31 | Financiado
FORECEE: Female cancer prediction using cervical omics to individualise screening and prevention ONCOTYROLCENTER FOR PERSONALIZED CANCER MEDICINE GMBH participó en un H2020: H2020-PHC-2014-2015 While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significan...
2015-03-27 - 2020-02-29 | Financiado
OPTATIO: OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma ONCOTYROLCENTER FOR PERSONALIZED CANCER MEDICINE GMBH participó en un FP7: Multiple Myeloma (MM) is an incurable disease with rapidly growing prevalence and poor prognosis. Consequently, it is the goal of the OPTATI...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.